GLP1R and Hypoglycemia: Lerche and co-workers [33] in randomized, double-blind placebo-controlled cross-over study in eight healthy men assessed the safety, in terms of hypoglycemia, of a continuously infused pharmacological dose of native GLP-1 during long-term fasting.